1. Garden AS, Harris J, Trotti A, Jones CU, Carrascosa L, Cheng JD, Spencer SS, Forastiere A, Weber RS, Ang KK (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71:1351–1355
2. Ang KK, Berkey BA, Tu X, Zhang H-Z, Katz R, Hammond EH et al (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 15:7350–7356
3. Sathyamurthy A, Koushik ASK, Gowri M, Janaki MG, Kilara N, Ponni TRA et al (2016) Impact of molecular predictors on the response rates in head and neck cancer patients – an observational study. Indian J Surg Oncol 7(4):380–385 Available from:
4. SEER Cancer Statistics Review 1975–2001 - Previous Version - SEER Cancer Statistics.
https://seer.cancer.gov/archive/csr/1975_2001/
. Accessed 27 Aug 2018
5. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58(1):5–13